CHLD
CHANGE OF OWNER RECEIVED FROM IB
01/01/2023
Back to search
Official data from USPTO
MN PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
01/01/2023
Trademark type
Combined
Nice classes
5, 44
Filing date
05/05/2006
Registration date
04/08/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2018
Last transaction
11/09/2018
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
TR
Examiner
BROMAGHIM, PETER
Law office
L70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the color blue appears in the wording "MN PHARMACEUTICALS" and in the circle design, the color white appears in the lettering "MN" inside the circle.
Holders and representatives
Holders
M. P. (pessoa física)
GENSENTA ILAÇ SANAYI VE TICARET ANONIM SIRKETI
M. A. (pessoa física)
Representatives
Rebecca L. Wilson The Dobrusin Law Firm P.C.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical Preparations For The Treatment Of Infectious DiseasesSkin Ands Soft Tissue InfectionsGastrointestinal InfectionsIntraabdominal InfectionsGynecological InfectionsRespiratory Tract InfectionsEndocarditisSepticemiaBone And Joint InfectionsNeoplastic DiseasesHematologic DisordersCardiovascular DiseasesEndocrine DisordersHypercalcemia Of MalignancyGastrointestinal DiseasesAllergic StatesRheumatic DisordersNervous System DisordersMuscle DiseasesNeuromuscular Blockage In General Anesthesia And As Imaging AgentsVeterinary Preparations For The Treatment Of Infectious Diseases; Sanitary Preparations For Medical Purposes; Dietetic Foods Adapted For Medical UseFood For Babies; Medical PlastersMaterials For Dressings; Material For Stopping TeethDental Wax; Disinfectants For Hygienic Purposes; Preparations For Destroying Vermin; FungicidesHerbicides
Class 44
Medical Services; Pharmaceutical Dispensing And Consultation Services; Veterinary Services; Hygienic And Beauty Care For Human Beings And Animals; AgricultureHorticulture And Forestry Services All For The Treatment Of Infectious DiseasesSkin And Soft Tissue InfectionsGastrointestinal InfectionsIntraabdominal InfectionsGynecological InfectionsRespiratory Tract InfectionsEndocarditisSepticemiaBone And Joint InfectionsNeoplastic DiseasesHematologic DisordersCardiovascular DiseasesEndocrine DisordersHypercalcemia Of MalignancyGastrointestinal DiseasesAllergic StatesRheumatic DisordersNervous System DisordersMuscle DiseasesNeuromuscular Blockage In General Anesthesia And As Imaging Agents
Publications
History of USPTO decisions and trademark events.
39 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/20/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/11/2022
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/24/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/30/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
12/30/2019
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/09/2019
C71T
CANCELLED SECTION 71
11/09/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/08/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
08/25/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/13/2013
71AG
REGISTERED-SEC.71 ACCEPTED
05/13/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2013
ES71
TEAS SECTION 71 RECEIVED
04/24/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/24/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/24/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/22/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/30/2008
FIMP
FINAL DISPOSITION PROCESSED
07/30/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/08/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2008
PUBO
PUBLISHED FOR OPPOSITION
01/22/2008
NPUB
NOTICE OF PUBLICATION
01/02/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/18/2007
ALIE
ASSIGNED TO LIE
12/07/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2007
RFNT
REFUSAL PROCESSED BY IB
08/02/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/13/2007
RFRR
REFUSAL PROCESSED BY MPU
07/13/2007
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/13/2007
CNRT
NON-FINAL ACTION WRITTEN
07/12/2007
DOCK
ASSIGNED TO EXAMINER
06/29/2007
NWAP
NEW APPLICATION ENTERED
06/29/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/28/2007
Continuous trademark protection
Get notified about every new filing that threatens MN PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.